跳至主要内容
临床试验/NCT02922660
NCT02922660已完成不适用

Comparison of Desflurane Balanced Anesthesia Versus TIVA-TCI (Total IntraVenous Anesthesia-Target Controlled Infusion) in Patients Undergoing Ophthalmic Ambulatory Surgery: A Single Center, Prospective, Randomized, Controlled Study

Xiaoliang Gan1 个研究点 分布在 1 个国家目标入组 209 人开始时间: 2016年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
209
试验地点
1
主要终点
Awake time

研究概览

简要总结

This is a single-center, randomized, prospective research which aims to investigate the advantages and disadvantages between desflurane balanced anesthesia and TIVA-TCI with propofol in ophthalmic ambulatory surgery, so that to evaluate a better anesthesia method in ophthalmic surgery through a large sample clinical study.

详细描述

Desflurane balanced anesthesia and TIVA-TCI(Total IntraVenous Anesthesia-Target Controlled Infusion) are commonly used in ophthalmic ambulatory surgery, however, there is no clear evidence to discriminate the advantages and disadvantages between them. This study is designed to evaluate a better anesthetic method in ophthalmic surgery through a clinical study. This is a single center, randomized, prospective study. 200 patients with American Society of Anesthesiologists'(ASA) physical status 1 to 2, aged 18 to 60, scheduled for elective strabismus ambulatory and in whom a LMA is indicated for anesthesia are recruited. Enrolled patients are randomly assigned into 2 groups: group TIVA (TIVA-TCI with propofol) and group Des (Desflurane).In group TIVA, anesthesia is maintained with propofol and remifentanil. Propofol is continuously administered via a target-controlled infusion (TCI) pump intraoperatively. In group Des, anesthesia is maintained with desflurane.All patients received anaesthesia depth monitoring with bispectral index (BIS). The dose of anesthetic is adjusted to maintained the BIS value within 40 to 60. At the end of the surgery, inhalant anesthetic or infused propofol and remifentanil are discontinued. LMA is removed when patient regains consciousness with spontaneous respiration. Patients are then transferred to the post anesthetic care unit (PACU) for postoperative follow-up. The primary outcome is awake time, the secondary outcomes include discharge time, the stay time in PACU, time of off-bed, Riker sedation agitation score (SAS), time of PADSS>9, NRS score when leaving PACU, incidence of various complications (postoperative nausea and vomiting (PONV), emergence agitation, etc), as well as anesthesia cost. All patients are followed up by calling in one day after the surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 18-60 years patients undergoing selective ophthalmic ambulatory surgery;
  • ASA I and II
  • duration of anesthesia at least 30min
  • without apparent organ comorbidities
  • sign the informed consent form

排除标准

  • equal or greater than ASA III
  • has a history of dementia,psychiatric disorders or central nervous system diseases
  • taking sedatives, antidepressant or glucocorticoid
  • without family members
  • has cardiac, respiratory,liver,kidney comorbidities
  • uncontrolled hypertension(>180/100mmHg)
  • laryngeal mask fail to insert, and change to tracheal intubation

研究组 & 干预措施

Group TIVA

Experimental

method of anesthesia is total intravenous anesthesia(TIVA) and maintenance with propofol Cp 2-4 μg/ml and remifentanil 2-4 ng/ml in target controlled infusion(TCI) during the procedure

干预措施: total intravenous anesthesia (Procedure)

Group TIVA

Experimental

method of anesthesia is total intravenous anesthesia(TIVA) and maintenance with propofol Cp 2-4 μg/ml and remifentanil 2-4 ng/ml in target controlled infusion(TCI) during the procedure

干预措施: Propofol (Drug)

Group TIVA

Experimental

method of anesthesia is total intravenous anesthesia(TIVA) and maintenance with propofol Cp 2-4 μg/ml and remifentanil 2-4 ng/ml in target controlled infusion(TCI) during the procedure

干预措施: Remifentanil (Drug)

Group Des

Experimental

method of anesthesia is inhalation anesthesia and maintenance with desflurane ranged from 0.5~1.5 MAC during the procedure

干预措施: desflurane (Drug)

Group Des

Experimental

method of anesthesia is inhalation anesthesia and maintenance with desflurane ranged from 0.5~1.5 MAC during the procedure

干预措施: inhalation anesthesia (Procedure)

结局指标

主要结局

Awake time

时间窗: From the ending time of anesthesia until the recovery time of patient's consciousness, assessed up to half an hour postoperatively.

"Anesthesia ends" means stop infusing or inhaling any anaesthetic.

次要结局

  • Postoperative VAS pain score(Start scaling in half an hour postoperatively when patient's consciousness returns.)
  • Discharge time(From the ending time of anesthesia until the time of extubation, assessed up to half an hour postoperatively.)
  • Stay time in the postoperative care unit(Measuring the stay time in postoperative care unit, assessed up to one hour postoperatively.)
  • Quality of recovery in 1 day postoperatively(Start scaling when 1 day(24 hour) postoperatively.)
  • Incidences in postoperative nausea and vomiting(PONV)(Start scaling in 1 day(24 hour) postoperatively.)
  • Anesthesia cost(During the procedure of anesthesia.)
  • Incidences in postoperative agitation(Start scaling in 1 day(24 hour) postoperatively.)

研究者

发起方
Xiaoliang Gan
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Xiaoliang Gan

associate chief physician

Sun Yat-sen University

研究点 (1)

Loading locations...

相似试验